Scarica l'app Stockscreener
13.23
3.15%
-0.43
Dopo l'orario di chiusura:
13.05
-0.18
-1.36%
Precedente Chiudi:
$13.66
Aprire:
$13.65
Volume 24 ore:
26,216
Relative Volume:
0.51
Capitalizzazione di mercato:
$59.84M
Reddito:
-
Utile/perdita netta:
$-24.77M
Rapporto P/E:
-18.12
EPS:
-0.73
Flusso di cassa netto:
$-17.36M
1 W Prestazione:
-5.77%
1M Prestazione:
-11.21%
6M Prestazione:
+79.27%
1 anno Prestazione:
+79.95%
Intervallo 1D:
$13.13
$13.75
Intervallo di 1 settimana:
$12.68
$14.25
Portata 52W:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Nome
Mink Therapeutics Inc
Settore
Industria
Telefono
212-994-8250
Indirizzo
149 FIFTH AVENUE, NEW YORK
Confronta INKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
13.23 | 61.78M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Borsa (INKT) Ultime notizie
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilientEarnings Performance Report & AI Powered Market Entry Strategies - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsTrade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
Mink Therapeutics Incfiles for mixed shelf offering up to $150 millionSEC filing - MarketScreener
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Breakouts & Breakdowns & Consistent Profit Alerts - newser.com
MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers - TradingView
MiNK reports durable responses with iNKT cell therapy in resistant tumors - Investing.com India
MiNK Therapeutics Reports Promising Clinical Results for agenT-797 in Treating PD-1 Resistant Cancers with Durable Survival and Immune Activation - Quiver Quantitative
Mink Therapeutics reports durable responses and immune reactivation with allo-iNKT cell therapy agent-797 in PD-1 refractory solid tumors at SITC 2025 - MarketScreener
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy ... - Enidnews.com
MiNK (NASDAQ: INKT) reports ~23-month median OS with agenT-797; no DLTs observed - Stock Titan
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationCPI Data & Reliable Breakout Forecasts - newser.com
Published on: 2025-11-07 02:44:18 - newser.com
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leadersJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Can trapped investors hope for a rebound in MiNK Therapeutics Inc.July 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
MiNK Therapeutics Inc. recovery potential after sell offPortfolio Gains Report & Accurate Buy Signal Notifications - newser.com
Can MiNK Therapeutics Inc. recover in the next quarterPortfolio Risk Report & AI Driven Price Forecasts - newser.com
What’s next for MiNK Therapeutics Inc. stock pricePortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soonWall Street Watch & Low Drawdown Investment Ideas - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyAnalyst Upgrade & AI Based Buy and Sell Signals - newser.com
Published on: 2025-11-06 01:04:02 - newser.com
Candlestick signals on MiNK Therapeutics Inc. stock todayEarnings Performance Report & Risk Controlled Swing Alerts - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock safe for risk averse investors2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
How resilient is MiNK Therapeutics Inc. stock in market downturnsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Published on: 2025-11-05 21:08:27 - newser.com
What Wall Street predicts for MiNK Therapeutics Inc. stock price2025 Stock Rankings & Weekly High Potential Stock Alerts - fcp.pa.gov.br
MiNK Therapeutics Inc. stock outlook for YEAR2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development - The Manila Times
MiNK Therapeutics to Release Q3 2025 Financial Results and Discuss Recent Clinical Progress on November 14th - Quiver Quantitative
MiNK Therapeutics to Report Third Quarter 2025 Financial - GlobeNewswire
MiNK Therapeutics (NASDAQ: INKT) to release Q3 2025 results; conference call scheduled - Stock Titan
Will MiNK Therapeutics Inc. stock benefit from sector rotationWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-05 05:01:18 - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock bottoming after sell offOil Prices & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-05 00:57:22 - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Will MiNK Therapeutics Inc. (6Q40) stock recover faster than industryJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves in volatile trading sessionsWeekly Risk Summary & Weekly High Potential Stock Alerts - newser.com
How to monitor MiNK Therapeutics Inc. with trend dashboardsMarket Performance Report & Free Accurate Trade Setup Notifications - newser.com
Published on: 2025-11-04 04:41:21 - newser.com
MiNK Therapeutics (NASDAQ:INKT) Trading Down 4.2%What's Next? - MarketBeat
Mink Therapeutics Inc Azioni (INKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):